Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Peter V who wrote (3440)	6/23/1998 10:20:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

Dr Maisels credentials speak for themselves: Dr. Maisels M. JEFFREY MAISELS, MB BCh Chairman, Department of Pediatrics William Beaumont Hospital Clinical Professor of Pediatrics Wayne State University School of Medicine and University of Michigan Medical School Royal Oak, Michigan Professor Maisels is internationally known for his work in neonatology, with special reference to hyperbilirubinemia. He has published over 250 articles, covering many aspects of neonatal medicine. Professor Maisels has served many organizations and on many committees. He has been Chairman of the Subspecialty Board in Neonatal/Perinatal Medicine of the American Board of Pediatrics, a consultant to the World Health Organization, and a task force member on quality assurance for the American Academy of Pediatrics. He is an Associate Editor of the Yearbook of Neonatal and Perinatal Medicine and was listed from 1992-1995 in the Best Doctors in America.

To: Peter V who wrote (3440)	6/23/1998 10:28:00 PM
From: Gurupup	Read Replies (2) \| Respond to of 5736

Peter V, >> Moreover, he is an interested party that owns a large number of shares in CCSI, and thus has a vested interest in its stock price. I'd be more inclined to believe a completely neutral third party, not someone that CCSI has paid to test and endorse its device, and who expresses opinions in an area in which he is not qualifie <<. It is my understanding that Dr. Maisels does not have a vested interest in CCSI. He does though, happen to be a believer in the technology, and honestly believes it will help in testing for bilirubin. A lot of people have expressed their feelings for me and about me, and I stand guilty of continuing to believe in CCSI. What has transpired in the marketplace is too well known. What I hope for the morrow is better news, and a rebuilding of broken careers, wallets, marriages, and lives. Blame it on me for being an optomist. Guilty, but I will still be here after you are all gone, because until the technology changes CCSI will do a deal.